Estimated effectiveness and cost-effectiveness of federally funded prevention efforts on gonorrhea rates in the United States, 1971-2003, under various assumptions about the impact of prevention funding

Sexually Transmitted Diseases

Volumn 33, Issue 10 SUPPL., 2006, Pages

  Chesson, Harrell W ^a,b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; FINANCIAL MANAGEMENT; GONORRHEA; HEALTH CARE COST; PUBLIC HEALTH SERVICE; SEXUALLY TRANSMITTED DISEASE; UNITED STATES;

CAPITAL FINANCING; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; FINANCING, GOVERNMENT; GONORRHEA; HUMANS; UNITED STATES;

EID: 33749019985     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000194575.79728.72     Document Type: Article

References (21)

1. Division of STD Prevention. Sexually Transmitted Disease Surveillance, 2003. Atlanta, GA: Centers for Disease Control and Prevention, 2004.
2. Centers for Disease Control and Prevention. Program Operations: Guidelines for STD Prevention. Atlanta, GA: Centers for Disease Control and Prevention, 2000.
3. Chesson HW, Harrison P, Scotton CR, et al. Does funding for HIV and sexually transmitted disease prevention matter? evidence from panel data. Eval Rev 2005; 29:3-23.
4. St Louis ME, Holmes KK. Conceptual framework for STD/HIV prevention and control. In: Holmes KK, Sparling PF, Mardh P, et al., eds. Sexually Transmitted Diseases. New York: McGraw-Hill, 1999: 1239-1253.
5. Chaulk CP, Zenilman J. Sexually transmitted disease control in the era of managed care: "magic bullet" or "shadow on the land"? J Public Health Manag Pract 1997; 3:61-70.
6. Brown ST, Wiesner PJ. Problems and approaches to the control and surveillance of sexually transmitted agents associated with pelvic inflammatory disease in the United States. Am J Obstet Gynecol 1980; 138:1096-1100.
7. Kamb ML, Fishbein M, Douglas JM Jr, et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. JAMA 1998; 280:1161-1167.
8. Holtgrave DR. Estimating the effectiveness and efficiency of US HIV prevention efforts using scenario and cost-effectiveness analysis. AIDS 2002; 16:2347-2349.
9. Gift TL, Haddix AC, Corso PS. Cost-effectiveness analysis. In: Haddix AC, Teutsch SM, Corso PA, eds. Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation. Oxford: Oxford University Press, 2003:156-177.
10. Gold MR, Siegel JE, Russell LB, et al., eds. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press, 1996.
11. Haddix AC, Teutsch SM, Corso PA, eds. Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation. Oxford: Oxford University Press, 2003.
12. Chesson HW, Blandford JM, Gift TL, et al. The estimated direct medical cost of sexually transmitted diseases among American youth, 2000. Perspect Sex Reprod Health 2004; 36:11-19.
13. Doubilet P, Begg CB, Weinstein MC, et al. Probabilistic sensitivity analysis using Monte Carlo simulation: a practical approach. Med Decis Making 1985; 5:157-177.
14. Becker MH, Joseph JG. AIDS and behavioral change to reduce risk: a review. Am J Public Health 1988; 78:394-410.
15. Feinleib JA, Michael RT. Reported changes in sexual behavior in response to AIDS in the United States. Prev Med 1998; 27:400-411.
16. Boily MC, Bastos FI, Desai K, et al. Changes in the transmission dynamics of the HIV epidemic after the wide-scale use of antiretroviral therapy could explain increases in sexually transmitted infections: results from mathematical models. Sex Transm Dis 2004; 31:100-113.
17. Chesson HW, Dee TS, Aral SO. AIDS mortality may have contributed to the decline in syphilis rates in the United States in the 1990s. Sex Transm Dis 2003; 30:419-424.
18. Boily MC, Brunham RC. The impact of HIV and other STDs on human populations: are predictions possible? Infect Dis Clin North Am 1993; 7:771-792.
19. Anderson RM, May RM. Infectious Diseases of Humans: Dynamics and Control. Oxford: Oxford University Press, 1991.
20. Cates W Jr. American Social Health Association Panel: estimates of the incidence and prevalence of sexually transmitted diseases in the United States. Sex Transm Dis 1999; 26:S2-S7.
21. Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases in American youth: incidence and prevalence estimates. Perspect Sex Reprod Health 2004; 36:6-10.